Pfizer Inc. has announced it is recalling all lots of its anti-smoking treatment drug, Chantix, due to what it says are high levels of carcinogens in the pills.
What’s a brief history here?
Pfizer in June announced it was pausing distribution of the drug due to the heightened levels of N-nitrosodimethylamine (NDMA) found in some of the drug’s lots.
At the time, the biopharmaceutical company said that the pause in distribution was “ordered out of an abundance of caution while further testing [was] is conducted.”
What are the details?
According to a Thursday Reuters report, the company announced it
Read more: Pfizer recalls Chantix smoking cessation drug over high levels of cancer-causing agents